Payments stocks react to Covid-19 vaccine

Payments stocks react to Covid-19 vaccine

Monday 9 November saw significant stock market moves following the news that a Covid-19 vaccine candidate developed by Pfizer and BioNTech was 90% effective in interim clinical trial results. How did the news impact the payments world?

payments stocks covid-19 vaccine

For companies that have benefited from lockdown, such as Peloton, Zoom and Netflix, this led to stark drops, but for payments companies it has been a story of two halves.

While those serving travel, consumer and B2B cross-border payments have seen their value surge on the prospect of international travel (and life) returning to normal, ecommerce companies saw their values drop as investors anticipated a slump in online spending. 

Of course, these are just interim results for a vaccine that still has to undergo several regulatory and manufacturing steps. However, it does provide a sense of how the market may adjust post-pandemic. 

Read More About
Valuations

Nuvei goes private: Inside the Advent International deal

April 11th, 2024

Stripe’s changing valuation

March 8th, 2024

How have cross-border payments stocks performed in 2023?

December 8th, 2023

+
Sign In
+
Account Registration
By creating an account, you agree to our
Terms and Conditions
+
Please enter your email address
We'll send you instructions on how to reset your password.
+